Literature DB >> 9708846

Chronic L-deprenyl treatment alters brain monoamine levels and reduces impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder.

F Boix1, S W Qiao, T Kolpus, T Sagvolden.   

Abstract

Effects of chronic L-deprenyl administration on hyperactive behaviour and brain monoamine levels were studied in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. SHR were hyperactive, impulsive and had impaired sustained attention when tested with a multiple 2-min fixed interval (FI) 5-min extinction (EXT) schedule of reinforcement. Even low, 0.25 mg/kg, doses of chronically-administered L-deprenyl reduced the impulsiveness (bursts of responses with short interresponse times) of SHR, without altering the general hyperactivity or the impaired sustained attention. The drug had no effect on WKY behaviour. The levels of noradrenaline (NA), dopamine (DA), serotonin (5-hydroxytryptamine, 5-HT) and their metabolites, measured in neostriatum, nucleus accumbens and frontal cortex, showed that L-deprenyl effectively inhibited monoamine oxidase (MAO) activity. These results suggest that impulsiveness is a behavioural component that may be operating independent of the other components, like hyperactivity and deficient sustained attention, and that can be reduced by chronic MAO-B inhibition with L-deprenyl in this strain of rats. The positive effect of L-deprenyl on impulsiveness is discussed as due either to normalization of an asymmetric dopaminergic activity in the nucleus accumbens, or to a restoration of normal DA function in the prefrontal cortex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708846     DOI: 10.1016/s0166-4328(97)00176-9

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  8 in total

1.  Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition.

Authors:  H K Wayment; J O Schenk; B A Sorg
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder.

Authors:  Douglas Teixeira Leffa; Bruna Bellaver; Carla de Oliveira; Isabel Cristina de Macedo; Joice Soares de Freitas; Eugenio Horacio Grevet; Wolnei Caumo; Luis Augusto Rohde; André Quincozes-Santos; Iraci L S Torres
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

3.  H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.

Authors:  Victoria A Komater; Kaitlin E Browman; Peter Curzon; Arthur A Hancock; Michael W Decker; Gerard B Fox
Journal:  Psychopharmacology (Berl)       Date:  2003-04-08       Impact factor: 4.530

4.  Effect of acute swim stress on plasma corticosterone and brain monoamine levels in bidirectionally selected DxH recombinant inbred mouse strains differing in fear recall and extinction.

Authors:  Caroline A Browne; Joachim Hanke; Claudia Rose; Irene Walsh; Tara Foley; Gerard Clarke; Herbert Schwegler; John F Cryan; Deniz Yilmazer-Hanke
Journal:  Stress       Date:  2014-12       Impact factor: 3.493

Review 5.  The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain.

Authors:  Terje Sagvolden; Espen Borgå Johansen; Grete Wøien; S Ivar Walaas; Jon Storm-Mathisen; Linda Hildegard Bergersen; Oivind Hvalby; Vidar Jensen; Heidi Aase; Vivienne A Russell; Peter R Killeen; Tania Dasbanerjee; Frank A Middleton; Stephen V Faraone
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

6.  Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats.

Authors:  Jean-Charles Bizot; Nicolas Chenault; Bérengère Houzé; Alexandre Herpin; Sabrina David; Stéphanie Pothion; Fabrice Trovero
Journal:  Psychopharmacology (Berl)       Date:  2007-04-04       Impact factor: 4.415

7.  Spatial memory in spontaneously hypertensive rats (SHR).

Authors:  Thomas-A Sontag; Anselm B M Fuermaier; Joachim Hauser; Ivo Kaunzinger; Oliver Tucha; Klaus W Lange
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

8.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.